Navigation Links
LifeMasters Introduces Health Activation Tool to Disease Management Participants
Date:3/2/2009

Innovator of the PAM™ Assessment in Chronic Disease Coaching

Irvine, Calif. (Vocus) March 2, 2009 -- In keeping with its commitment to implement the latest advances in behavior change, LifeMasters Supported SelfCare, Inc. is the first disease management company in the country to introduce a powerful health activation tool for use with its chronically ill participants.

The Patient Activation Measure™ (PAM™) was developed by Judith Hibbard, Ph.D., and colleagues at the University of Oregon to assess an individual's knowledge, skills and confidence in playing a role in one's own health and healthcare. By understanding participants' "activation levels," LifeMasters health professionals can better tailor participant coaching to an individual's level of activation, helping him or her identify and overcome barriers to behavior change.

"We know that higher levels of activation are correlated with improved self-care behaviors," said LifeMasters CEO Christobel Selecky. "By focusing on increasing a participant's activation level, our health coaches can help LifeMasters participants to develop self-efficacy and greater levels of motivation, which ultimately lead to greater confidence in managing their health. We are very excited about the potential that this tool provides us to improve outcomes and enhance sustained engagement."    

LifeMasters is a health improvement company with more than 15 years experience in developing scientifically based interventions that target key cost drivers such as diabetes, congestive heart failure, asthma, coronary artery disease, chronic obstructive pulmonary disease, hypertension, cancer and musculo-skeletal pain. The company began piloting the PAM in 2005.
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. LifeMasters Offers Financial Incentives to Florida Physicians for Participation in Disease Management Programs
2. Research Shows Successful Physician Engagement in LifeMasters Disease Management Programs
3. LifeMasters Receives Full Accreditation for Disease Management Programs
4. LifeMasters Receives 2008 Vision Award for Business Impact
5. LifeMasters Announces Agreement to Offer Disease Management Services to High-Risk Wisconsin Residents
6. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
7. The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida
8. LifeMasters Receives Full URAC Disease Management Accreditation
9. Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience
10. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
11. Smith & Nephew Introduces Metal Liner Option for the Modular R3(TM) Acetabular Cup System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ndomized, controlled study comparing standard cons... called percutaneous disc decompression for painfu...ts help patients in the short run, only disc decom...ater. Results of the study, the first of its kind,... Radiological Society of North America (RSNA). , ...
(Date:12/1/2009)... Advocate Christ Medical Center in Oak L...ey transplant center and the first for Chicago&rsq... approval of the hospital’s plans today (Dec...vices Review Board. , Spr... Center in Oak Lawn, Ill. has become the state&rs...
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.c...available in its catalogue: ,, Emerging Clini...he changing healthcare and regulatory environment ...ging-Clinical-Trial-Locations---India-Market-dynam...ironment.html ,, Over the last decade pharmace...
(Date:12/1/2009)...INGTON, Dec. 1 The Kerl...ic in Los Angeles, has agreed to pay the United St...ived illegal kickbacks from HealthSouth Corporatio..., The settlement resolves allegations that Healt...f stock option grants, donations to the Kerlan Job...
(Date:12/1/2009)... ANGELES, Dec. 1 A decision issued...r Relations Board (NLRB) has put at risk the guara... Kaiser Permanente RNs, social workers, and profes...ked for years to achieve standards at Kaiser that ...ssional care our patients need," said Jeanette Cry...
Breaking Medicine News(10 mins):Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2
...s for Rapid Onsite Pathogen Detection , , ST. GEO...response to the recent outbreak of swine flu and r... test for its GeneSTAT(R) pathogen detection platf...ounds. The Company anticipates having a product r...
...ation,s leader in pain prescription monitoring, an...ment with Aetna to offer Aetna,s network of provid... medication monitoring process. , , Ameritox,s p...patients are taking their pain medication consiste...
...ns believe there is some risk for a catastrophic p...ational study among 2,225 members of the general p...hat there is some risk that the current situation ... study was conducted by HCD Research and the Muhl...
...n,s largest organization of registered nurses toda...ontainment and prevention of a broader swine flu p...tion,s call on Congress Tuesday to allocate $1.5 b...healthcare infrastructure badly eroded after years...
...ction with HBO, Cox Communications will allow all ...scribe to HBO -- to have free access to its upcomi...eginning May 11, digital cable customers can acces... , , "Cox is happy to partner with HBO to presen...
...d Officials to Pass Community Choice Act , , WASH...DAPT disability rights organization, and home care...the halls of Congress today to deliver an urgent m...mericans. , , The rally was part of a larger effo...
Other Medicine News:Health News:DxNA to Use its Rapid Detection Platform to Simplify Testing for Swine Flu (H1N1 Virus) 2Health News:DxNA to Use its Rapid Detection Platform to Simplify Testing for Swine Flu (H1N1 Virus) 3Health News:Ameritox(R) Contracts With Aetna for Prescription Drug Monitoring Services 2Health News:General Public and Physicians Express Similar Levels of Concern Regarding Potential Swine Flu Pandemic 2Health News:General Public and Physicians Express Similar Levels of Concern Regarding Potential Swine Flu Pandemic 3Health News:General Public and Physicians Express Similar Levels of Concern Regarding Potential Swine Flu Pandemic 4Health News:Nurses Call for Broader Action to Combat Swine Flu: Boost Public Health, Moratorium on Closures, Layoffs, Suspend Insurance Charges that Discourage Prevention 2Health News:Nurses Call for Broader Action to Combat Swine Flu: Boost Public Health, Moratorium on Closures, Layoffs, Suspend Insurance Charges that Discourage Prevention 3Health News:Cox Offers Free Access to HBO(R) Documentary Series, The Alzheimer's Project, to All Digital Customers 2Health News:ADAPT Disability Rights Activists and SEIU Home Care Attendants Tell Congress: Community Choice is a Right 2
(Date:12/2/2009).... 2 Novartis announced today that ...n Tasigna® (nilotinib) 200 mg capsules in a f...trength of the company,s hematology portfolio in a..., at the 51st American Society of Hematology (ASH)...any,s current therapies and investigational agents...
(Date:12/1/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Medical Oxygen Systems - Global Market Opp...164334/Medical-Oxygen-Systems---Global-Market-Oppo...tems market for home healthcare setting is reckone...th expectations stem from demographic factors such...
(Date:12/1/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Molecular Diagnostics - A World Market Revi...lecular-Diagnostics---A-World-Market-Review.html ... by several growth factors that include the need f...combine optimized sample preparation, analysis, an...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6LifeNet Health Announces First Bio Implant with New Preservation Technology 6088 1LifeNet Health Announces First Bio Implant with New Preservation Technology 6088 2RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas Fort Worth Area 6084 1RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas Fort Worth Area 6084 2Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 1Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 2Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 3Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 4Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 5Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 6Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 7
... EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Jun 6, 200...nnounced today that two,abstracts exploring Phase ...fe in treatment-failure gout patients will be,pres...ULAR) 2007,Annual Congress taking place June 13 - ...recombinant porcine urate oxidase currently,in Pha...
... SAN DIEGO--(BUSINESS WIRE)--Jun 7, 2007 - Inovio ...development of DNA vaccines,for cancers and infect...o treat localized cancers, announced today that th... positive interim,safety and tolerability data on ... using Inovio,s electroporation technology for,int...
Other Medicine Technology:Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 2Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 3Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 4Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 2Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 3Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 4Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 5
Tying Forceps - Curved
Nordan Straight Tying Forceps
McPherson Angled Tying Forceps
Clayman - McPherson Angled Tying Forceps
Medicine Products: